NEM
Newmont
$112.54
▲ 6.7%Updated Aug 7, 11:30 AM ET
NEM at a glance — five pillars scored 0–100 from real filed financials.
Overall: Strong · 86/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 78.1% over the last 12 months
Market Cap
$103.60B
P/E
14.21x
Forward P/E (est.)
10.15x
ROE
25.2%
Revenue Growth
26.9%
EPS Growth
73.1%
Profit Margin
33.9%
FCF Yield
1.3%
Debt / Equity
0.17x
ROIC
—
Interest Coverage
—
Current Ratio
2.44x
Dividend Yield
1.0%
Implied Growth (rev. DCF)
1.8%
Rating Score
86/100
Newmont (NEM) is a large-cap company in the Gold industry, part of the Materials sector of the S&P 500, with a market value around $103.60B.
In its latest reported year it generated about $22.67B in revenue and $7.08B in net profit.
Our model rates NEM Strong (86/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what NEM's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. NEM trades near $112.54, above its 50-day average ($106.55) and 200-day average ($103.33). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 49 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. NEM's is $4.25 (~3.8% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month NEM found buyers near $91.71 (support) and sellers near $112.18 (resistance); its 52-week range is $55.37–$134.88. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.9× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
16.7%
Revenue moved from $6.68B in 2016 to $22.67B in 2025, a 14.5% compound annual growth rate. The most recent year grew a strong 26.9% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
68.3%
Operating Margin
52.4%
Net Margin
31.3%
ROE
25.2%
Newmont keeps about 33.9% of each sales dollar as net profit, with a 68.3% gross margin and 52.4% operating margin. Return on equity is 25.2%. Margins this wide usually signal pricing power or a cost advantage.
Total Debt
$5.08B
Net Debt
-$3.70B
Net cash position
Net Debt / EBITDA
—
Debt / Equity
0.17x
Leverage: debt-to-equity is 0.2x, with a current ratio of 2.4x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $5.08B of total debt against $8.78B of cash.
Operating CF
$10.33B
Free Cash Flow
$7.30B
FCF Margin
32.2%
In the latest year Newmont produced about $10.33B of operating cash flow and $7.30B of free cash flow after capital spending. That is a free-cash-flow yield of about 1.3% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Dividend yield
1.0%
Per share (latest FY)
$1.00
Total paid (latest FY)
$1.11B
History on record
10 years
dividend uses 15% of free cash flow
16% of net income paid out
no current raise streak
payout was cut at least once in the last 10 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
14.21x
P/S
5.11x
P/B
3.34x
EV / EBITDA
—
NEM trades at 14.2x trailing earnings (about 10.1x on estimated forward earnings), 5.1x sales, and 3.3x book value. Reverse-engineering today's price implies the market expects roughly 1.8% long-term free-cash-flow growth. That is an undemanding multiple — potentially cheap if the business is stable.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$283.13
Current price
$112.54
Starting FCF (latest 10-K)
$7.30B
Growth, years 1–5
20.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where NEM sits versus its Materials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 54 Materials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How NEM stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (78 S&P 500 companies), NEM ranks #8 of 78 by our overall rating. It trades at a discount versus the sector on earnings (14.2x P/E vs. 22.7x median) with a higher return on equity (25.2% vs. 16.1%) and faster revenue growth (26.9% vs. 7.9%).
P/E vs sector
14.2x
median 22.7x
ROE vs sector
25.2%
median 16.1%
Growth vs sector
26.9%
median 7.9%
Sector rank
#8
of 78 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 78 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $112.54 today · expected CAGR 12% – 26%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $28.79B | $36.56B | $46.43B | $58.97B | $74.89B |
| Net income | $8.92B | $11.33B | $14.39B | $18.28B | $23.22B |
| EPS | $9.70 | $12.31 | $15.64 | $19.86 | $25.22 |
| Share price (low) | $77.56 | $98.50 | $125.10 | $158.88 | $201.78 |
| Share price (high) | $135.74 | $172.38 | $218.93 | $278.04 | $353.11 |
| CAGR (low–high) | -31% / 21% | -6% / 24% | 4% / 25% | 9% / 25% | 12% / 26% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for NEM:
- Revenue is growing 26.9% a year, a sign of real demand.
- High net margins (33.9%) point to pricing power or efficiency.
- Strong return on equity (25.2%) shows capital is put to work well.
- A conservative balance sheet (debt/equity 0.2x) lowers risk.
- Our model's overall read is Strong (86/100).
The case against NEM:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen favourably: Newmont is a large-cap materials business still growing nicely, with solid profitability, and a sound balance sheet. It trades at 14.2x earnings, which our model scores Strong (86/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 31 Wall Street analysts covering NEM recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+4 pts of buy ratings).
Latest SEC Filings
NEM's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
NEM — frequently asked questions
Is NEM a good stock to buy?
We don't give buy or sell advice. Our model rates Newmont Strong (86/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is NEM's rating on The Stocks School?
Newmont currently scores 86/100 (Strong) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does NEM's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Newmont's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for NEM calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this NEM analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell NEM. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.